O

OrbiMed Portfolio holdings

AUM $4.17B
1-Year Est. Return 30.9%
This Quarter Est. Return
1 Year Est. Return
+30.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.98B
AUM Growth
-$187M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
122
New
Increased
Reduced
Closed

Top Buys

1
+$81.1M
2
+$42.1M
3
+$31.3M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.4M
5
CTMX icon
CytomX Therapeutics
CTMX
+$19.2M

Top Sells

1
+$97.6M
2
+$76.6M
3
+$62.4M
4
SWTX
SpringWorks Therapeutics
SWTX
+$41.9M
5
XTNT icon
Xtant Medical Holdings
XTNT
+$34.4M

Sector Composition

1 Healthcare 99.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBX
26
MBX Biosciences
MBX
$1.11B
$45.7M 1.14%
4,002,887
AXSM icon
27
Axsome Therapeutics
AXSM
$6.93B
$44.7M 1.12%
427,900
+41,200
CMPX icon
28
Compass Therapeutics
CMPX
$848M
$39.6M 0.99%
15,219,994
-7,142,856
CYTK icon
29
Cytokinetics
CYTK
$8.01B
$35.6M 0.89%
1,077,000
-432,205
CRNX icon
30
Crinetics Pharmaceuticals
CRNX
$4.05B
$33M 0.83%
1,149,000
+150,000
EXAS icon
31
Exact Sciences
EXAS
$12.7B
$32.3M 0.81%
607,316
-72,500
THRD
32
DELISTED
Third Harmonic Bio
THRD
$31.4M 0.78%
5,779,071
ROIV icon
33
Roivant Sciences
ROIV
$14.1B
$31.3M 0.78%
+2,779,427
XENE icon
34
Xenon Pharmaceuticals
XENE
$3.15B
$29.7M 0.74%
947,877
NPCE icon
35
Neuropace
NPCE
$431M
$29.1M 0.73%
2,614,184
-792,151
CRVS icon
36
Corvus Pharmaceuticals
CRVS
$597M
$28.7M 0.72%
7,165,006
+221,352
TERN icon
37
Terns Pharmaceuticals
TERN
$2.03B
$28.2M 0.7%
7,562,971
JANX icon
38
Janux Therapeutics
JANX
$1.76B
$28M 0.7%
1,210,300
+451,734
APLS icon
39
Apellis Pharmaceuticals
APLS
$2.51B
$25.7M 0.64%
1,482,300
+50,000
GPCR icon
40
Structure Therapeutics
GPCR
$2.23B
$24.9M 0.62%
1,199,300
+547,272
SCPH
41
DELISTED
scPharmaceuticals
SCPH
$23.1M 0.58%
6,059,528
CTMX icon
42
CytomX Therapeutics
CTMX
$657M
$19.2M 0.48%
+8,461,500
TMO icon
43
Thermo Fisher Scientific
TMO
$217B
$18.9M 0.47%
46,500
-82,500
AGIO icon
44
Agios Pharmaceuticals
AGIO
$2.48B
$18.6M 0.46%
557,900
+232,400
TRVI icon
45
Trevi Therapeutics
TRVI
$1.38B
$18.1M 0.45%
3,308,400
+2,188,400
ADCT icon
46
ADC Therapeutics
ADCT
$502M
$15.8M 0.4%
5,907,351
-61,100
RYTM icon
47
Rhythm Pharmaceuticals
RYTM
$6.63B
$15.7M 0.39%
248,512
-131,488
FBRX icon
48
Forte Biosciences
FBRX
$175M
$15.5M 0.39%
1,196,955
+603,867
CGEM icon
49
Cullinan Oncology
CGEM
$505M
$14.5M 0.36%
1,923,855
KROS icon
50
Keros Therapeutics
KROS
$526M
$13.6M 0.34%
1,018,734
1
2
3 4 5